Every material Form 8-K Quanterix Corp has filed with the SEC since May 26, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Quanterix reported third-quarter 2026 revenue of $35.0 million, up 6.3% from the second quarter but down from $40.2 million a year earlier, and a net loss of $21.6 million, compared with $33.5 million a year earlier. The company narrowed its 2026 total revenue outlook to $142-146 million, which gives shareholders a clearer range for the full year.
Q3 2026 revenue of $35.0 million, compared with $40.2 million in Q3 2025 and up 6.3% from Q2 2026.
Net loss of $21.6 million, or $0.46 per share, compared with a net loss of $33.5 million, or $0.73 per share, a year earlier.
2026 total revenue outlook narrowed to $142-146 million; adjusted gross margin expectation of 48-50% unchanged; year-end cash expected at about $70 million with no debt.
Cash, cash equivalents, marketable securities and restricted cash totaled $80.7 million at September 30, 2026.
Quanterix reported second-quarter 2026 revenue of $32.9 million, up 34% from $24.5 million a year earlier, but its net loss widened to $48.9 million, or $1.04 per share, including a $26.9 million goodwill impairment tied to the Akoya acquisition. The company cut its 2026 revenue outlook to $142-148 million from $169-174 million and lowered its expected year-end 2026 cash balance to about $80 million from $100 million.
Q2 2026 revenue was $32.9 million, up 34% from $24.5 million; net loss was $48.9 million, or $1.04 per share, versus $30.0 million, or $0.77 per share, in Q2 2025.
2026 revenue outlook was lowered to $142-148 million from $169-174 million, and non-GAAP gross margin guidance is now 48-50% versus 49-53% previously.
Cash flow breakeven is now expected in 2027, and year-end 2026 cash is forecast at about $80 million versus $100 million previously.
Jim Gute was named Chief Commercial Officer, announced alongside the results.
Quanterix appointed Jason Faessler as Chief Financial Officer and Treasurer, with employment expected to begin June 22, 2026. He previously led global FP&A and the Americas finance organization at Bruker Corporation, and the filing sets out his pay and severance terms.
Employment agreement dated May 31, 2026 provides an initial annualized base salary of $475,000 and a cash sign-on bonus of $200,000.
Annual bonus target of up to 50% of base salary.
Restricted stock units equal to 0.30% of common shares outstanding on his start date, vesting in four equal annual installments.
Severance includes 12 months of base salary and a pro-rated target bonus; full equity vesting applies if the termination is tied to a change in control.
Quanterix appointed Anthony Catalano as Chief Operating Officer effective with his May 14, 2026 appointment, under an employment agreement with a $400,000 base salary and a $50,000 sign-on bonus. Former COO Michael Miller moved to the new role of Chief Technology and Products Officer. The change at the top operations post is a leadership change that shareholders may want to follow, but the filing reports no financial results.
Anthony Catalano appointed Chief Operating Officer on May 14, 2026; agreement sets $400,000 base salary, $50,000 sign-on bonus and annual bonus target up to 50% of base salary
Catalano received RSUs equal to 0.30% of common shares outstanding on his start date, vesting in four equal annual installments
Michael Miller, formerly COO, transitioned to Chief Technology and Products Officer
Catalano previously worked at Akoya Biosciences, which Quanterix acquired, from July 2025 to August 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Quanterix Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →